| Cecilia Daily, | |
|
9426 Lima Rd Ste A, Fort Wayne, IN 46818-8681 | |
| (260) 497-0328 | |
| Not Available |
| Full Name | Cecilia Daily |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 9426 Lima Rd Ste A, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033770854 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 46003394A (Indiana) | Primary |
| Provider Name | Turnstone Center For Children And Adults With Disabilities, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437158722 PECOS PAC ID: 8527401744 Enrollment ID: O20240205002965 |
News Archive
The out-of-hospital birth setting in Oregon was associated with a higher risk of perinatal death, while the in-hospital birth setting was associated with a higher risk for cesarean delivery and other obstetric interventions (e.g., induction or augmentation of labor), according a study published today in the New England Journal of Medicine by researchers at Oregon Health & Science University.
The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs.
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).
The fact that people are living longer lives represents one of the crowning achievements of the last century, but also requires careful planning on the part of governments.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced that Synjardy (empagliflozin/metformin hydrochloride) tablets are now available by prescription in pharmacies across the United States.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cecilia Daily, 9426 Lima Rd Ste A, Fort Wayne, IN 46818-8681 Ph: (260) 497-0328 | Cecilia Daily, 9426 Lima Rd Ste A, Fort Wayne, IN 46818-8681 Ph: (260) 497-0328 |
News Archive
The out-of-hospital birth setting in Oregon was associated with a higher risk of perinatal death, while the in-hospital birth setting was associated with a higher risk for cesarean delivery and other obstetric interventions (e.g., induction or augmentation of labor), according a study published today in the New England Journal of Medicine by researchers at Oregon Health & Science University.
The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs.
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).
The fact that people are living longer lives represents one of the crowning achievements of the last century, but also requires careful planning on the part of governments.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced that Synjardy (empagliflozin/metformin hydrochloride) tablets are now available by prescription in pharmacies across the United States.
› Verified 6 days ago
Michelle A Ludlow, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 808 Mill Lake Rd, Fort Wayne, IN 46845 Phone: 260-338-1241 Fax: 260-338-1231 | |
Josie Lyn Johnson, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5250 Heritage Pkwy, Fort Wayne, IN 46835 Phone: 260-209-6279 | |
Linda Sue Sickman, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1717 Maplecrest Rd, Fort Wayne, IN 46815 Phone: 260-493-0012 | |
Jennifer Lynn Garrett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6329 Mapledowns Dr, Fort Wayne, IN 46835 Phone: 260-433-7903 | |
Jennifer Wilson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 808 Mill Lake Rd, Fort Wayne, IN 46845 Phone: 260-338-1241 Fax: 260-338-1231 | |
Mrs. Toni Walker Blackwood, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1923 Brandywine Trl, Fort Wayne, IN 46845 Phone: 260-637-3117 | |
Mrs. Kimberly A Griffith, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6205 Constitution Dr, Fort Wayne, IN 46804 Phone: 260-438-3586 Fax: 877-992-0273 |